Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Thaiz Rivera Vargas"'
Autor:
Pauline Soulas-Sprauel, Bernhard Ryffel, Corentin Richard, Romain Boidot, Elise Jacquin, Raphael Carapito, Richard A Flavell, Frederique Vegran, Tiffany Martin, Isis Benoit-Lizon, Thaiz Rivera Vargas, Aurélie Roussey, Ludivine Dal Zuffo, Andréa Melis, Daria Vinokurova, Sayyed Hamed Shahoei, Alvaro Baeza Garcia, Cassandre Pignol, Stéphane Giorgiutti, Eric R Nelson, Toby Lawrence, Lionel Apetoh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/010efbccc7be494cbe7e79e2e8c14071
Autor:
Thaiz Rivera Vargas, Zhijian Cai, Yingying Shen, Magalie Dosset, Isis Benoit-Lizon, Tiffany Martin, Aurélie Roussey, Richard A. Flavell, François Ghiringhelli, Lionel Apetoh
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-16 (2017)
Autophagy is a cellular process for recycling cell constituents, and is essential for T cell activation, but its function in T cell polarization is still unclear. Here the authors show that autophagy induces the degradation of transcription factor PU
Externí odkaz:
https://doaj.org/article/ef5f37a4be9a43188f9b499831b2af44
Autor:
Thaiz Rivera Vargas, Lionel Apetoh
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The unprecedented clinical activity of checkpoint blockade in several types of cancers has formally demonstrated that anti-tumor immune responses are crucial in cancer therapy. Durable responses seen in patients treated with immune checkpoint inhibit
Externí odkaz:
https://doaj.org/article/0611a5c91e584184913b5be54af6d46e
Publikováno v:
Cells, Vol 9, Iss 7, p 1727 (2020)
Immune checkpoint inhibitors (ICPi) have shown their superiority over conventional therapies to treat some cancers. ICPi are effective against immunogenic tumors. However, patients with tumors poorly infiltrated with immune cells do not respond to IC
Externí odkaz:
https://doaj.org/article/4f4edb4dff73479e8e6760ff2c17fc1d
Autor:
Magalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange, Romain Boidot, Frédérique Végran, Aurélie Roussey, Fanny Chalmin, Lucile Dondaine, Catherine Paul, Elodie Lauret Marie-Joseph, François Martin, Bernhard Ryffel, Christophe Borg, Olivier Adotévi, François Ghiringhelli, Lionel Apetoh
Publikováno v:
OncoImmunology, Vol 7, Iss 6 (2018)
Background: Chemotherapy is currently evaluated in order to enhance the efficacy of immune checkpoint blockade (ICB) therapy in colorectal cancer. However, the mechanisms by which these drugs could synergize with ICB remains unclear. The impact of ch
Externí odkaz:
https://doaj.org/article/3108ad73e6a64718a3c8e9ecc4b0865e
Autor:
Jeremie Kropp, Anna Polesskaya, Evgeny Deforzh, Marie Vandamme, Thaiz Rivera Vargas, Guillaume Pinna
Publikováno v:
International Journal of Oncology
International Journal of Oncology, Spandidos Publications, 2016, 〈https://www.spandidos-publications.com/ijo/49/6/2578〉. 〈10.3892/ijo.2016.3750〉
International Journal of Oncology, Spandidos Publications, 2016, ⟨10.3892/ijo.2016.3750⟩
International Journal of Oncology, 2016, ⟨10.3892/ijo.2016.3750⟩
International Journal of Oncology, Spandidos Publications, 2016, 〈https://www.spandidos-publications.com/ijo/49/6/2578〉. 〈10.3892/ijo.2016.3750〉
International Journal of Oncology, Spandidos Publications, 2016, ⟨10.3892/ijo.2016.3750⟩
International Journal of Oncology, 2016, ⟨10.3892/ijo.2016.3750⟩
International audience; IGF-2 mRNA binding protein 3 (IGF2BP3, IMP-3) is a well-known post-transcriptional regulatory factor of gene expression, mainly involved in embryonic development and oncogenesis. We have previously demonstrated that a subset o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ff5b79ea75d5786f1796147d9411ea
https://doi.org/10.3892/ijo.2016.3750
https://doi.org/10.3892/ijo.2016.3750
Autor:
Lionel Apetoh, Thaiz Rivera Vargas
Publikováno v:
Oncoimmunology ISBN: 9783319624303
The aim of chemotherapy and radiotherapy is to eliminate tumor cells. While the outcomes of these cytotoxic treatments were previously attributed to their direct effects on tumor cells, it is now clear that the host’s immune system, and specificall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b532e7dae8fc16e6f144d5d1830b888b
https://doi.org/10.1007/978-3-319-62431-0_5
https://doi.org/10.1007/978-3-319-62431-0_5
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2017, 75, pp.86-97. 〈10.1016/j.ejca.2016.12.028〉
European Journal of Cancer, Elsevier, 2017, 75, pp.86-97. ⟨10.1016/j.ejca.2016.12.028⟩
European Journal of Cancer, Elsevier, 2017, 75, pp.86-97. 〈10.1016/j.ejca.2016.12.028〉
European Journal of Cancer, Elsevier, 2017, 75, pp.86-97. ⟨10.1016/j.ejca.2016.12.028⟩
International audience; The efficacy of checkpoint inhibitor therapy illustrates that cancer immunotherapy, which aims to foster the host immune response against cancer to achieve durable anticancer responses, can be successfully implemented in a rou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b8b8724b25cf5b2bbaf1a5a53639417
http://www.hal.inserm.fr/inserm-01483047/document
http://www.hal.inserm.fr/inserm-01483047/document
Autor:
Lionel Apetoh, Thaiz Rivera Vargas
Publikováno v:
Immunological Reviews
Immunological Reviews, Wiley, 2017, 280 (1), pp.175-193. 〈http://onlinelibrary.wiley.com/doi/10.1111/imr.12581/abstract;jsessionid=F14865234610652B47041BC529617BB3.f03t03〉. 〈10.1111/imr.12581〉
Immunological Reviews, Wiley, 2017, 280 (1), pp.175-193. ⟨10.1111/imr.12581⟩
Immunological Reviews, Wiley, 2017, 280 (1), pp.175-193. 〈http://onlinelibrary.wiley.com/doi/10.1111/imr.12581/abstract;jsessionid=F14865234610652B47041BC529617BB3.f03t03〉. 〈10.1111/imr.12581〉
Immunological Reviews, Wiley, 2017, 280 (1), pp.175-193. ⟨10.1111/imr.12581⟩
IF 9.614; International audience; Endogenous danger signals are molecules normally present in a given cell compartment that are rapidly released following cell stress and induce immune responses. We and others have shown that dying tumor cells treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f966ba5ec78fea99f4b5fe29836f82
Publikováno v:
Current Opinion in Pharmacology
Current Opinion in Pharmacology, Elsevier, 2017, 35, pp.83-88. ⟨10.1016/j.coph.2017.05.003⟩
Current Opinion in Pharmacology, Elsevier, 2017, 〈http://www.sciencedirect.com/science/article/pii/S147148921730019X〉. 〈10.1016/j.coph.2017.05.003〉
Current Opinion in Pharmacology, Elsevier, 2017, 35, pp.83-88. ⟨10.1016/j.coph.2017.05.003⟩
Current Opinion in Pharmacology, Elsevier, 2017, 〈http://www.sciencedirect.com/science/article/pii/S147148921730019X〉. 〈10.1016/j.coph.2017.05.003〉
IF 5.363; International audience; Impressive remissions driven by immunological checkpoint blockade in cancer patients have prompted the scientific community to investigate afresh the crosstalk between cancer cells and the patient's immune system. Pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393024364de576c4339b44d7ccba609d